News
VESPER-1 and interim VESPER-3 data release expected in September 2025; Phase 3 initiation on track for late 2025 MET-233i (once-monthly amylin analog) delivered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback